SeQuent Scientific Overview
- Year Founded
-
1985
- Status
-
Public
- Employees
-
1,358
- Stock Symbol
-
512529
- Investments
-
8
- Share Price
-
$2.45
- (As of Tuesday Closing)
SeQuent Scientific General Information
Description
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.
Contact Information
Website
www.sequent.inCorporate Office
- 301/A, 3rd Floor, Dosti Pinnacle
- Plot Number E7, Road Number 22, Wagle Industrial Area, Thane (West)
- Mumbai, Maharashtra 400604
- India
Corporate Office
- 301/A, 3rd Floor, Dosti Pinnacle
- Plot Number E7, Road Number 22, Wagle Industrial Area, Thane (West)
- Mumbai, Maharashtra 400604
- India
SeQuent Scientific Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.45 | $2.37 | $1.09 - $2.87 | $611M | 249M | 312K |
SeQuent Scientific Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 403,160 | 398,978 | 273,308 | 475,803 |
| Revenue | 171,273 | 165,040 | 176,627 | 189,266 |
| EBITDA | 15,431 | 6,359 | (6,657) | 15,802 |
| Net Income | 660 | (4,333) | (15,089) | 5,497 |
| Total Assets | 184,713 | 186,249 | 191,350 | |
| Total Debt | 0 | 58,481 | 54,030 | 48,122 |
SeQuent Scientific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SeQuent Scientific Comparisons
Industry
Financing
Details
SeQuent Scientific Competitors (54)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis India | Corporation | Mumbai, India | ||||
| Strides Pharma Science | Corporation | Bangalore, India | ||||
| Abbott India | Corporation | Mumbai, India | ||||
| Ajanta Pharma | Corporation | Mumbai, India | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India |
SeQuent Scientific Patents
SeQuent Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140100385-A1 | Process for preparation of succinylcholine chloride | Inactive | 08-Oct-2012 | ||
| EP-2651225-A2 | A process for preparation of praziquantel | Inactive | 13-Dec-2010 | ||
| EP-2651225-A4 | A process for preparation of praziquantel | Inactive | 13-Dec-2010 | ||
| US-20130289275-A1 | Process for the preparation of praziquantel | Active | 13-Dec-2010 | ||
| US-8754215-B2 | Process for the preparation of praziquantel | Active | 13-Dec-2010 | C07C237/08 |
SeQuent Scientific Executive Team (9)
| Name | Title | Board Seat |
|---|---|---|
| Kamal Sharma Ph.D | Chairman & Independent Director | |
| Sharat Narasapur | Joint Managing Director | |
| Ashish Kakabalia | Vice President, Business Development & International Formulations | |
| Rajaram Narayanan | Chief Executive Officer, Managing Director & Board Member | |
| Saurav Bhala | Chief Financial Officer |
SeQuent Scientific Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Board Member | ||
| SeQuent Scientific | Chairman & Independent Director | ||
| Self | Chairman | ||
| Self | Board Member & Managing Director | ||
| Self | Board Member |
SeQuent Scientific Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SeQuent Scientific Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SeQuent Scientific Investments & Acquisitions (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Viyash Life Sciences | 26-Sep-2024 | Pharmaceuticals | |||
| Tineta Pharma | 07-Nov-2022 | Other Consumer Non-Durables | |||
| Solara Active Pharma Sciences (EU-GMP API facility located at Mahad, Maharashtra) | 01-Aug-2018 | Buildings and Property | |||
| Naari Pharma India | 01-Jan-2016 | Pharmaceuticals | |||
| Alivira Animal Health | 31-Mar-2015 | Secondary Transaction - Private | Pharmaceuticals |
SeQuent Scientific Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Alivira Animal Health | Pharmaceuticals | Mumbai, India | 2013 |
| SeQuent Scientific (Pharmaceutical Ingredient Unit in Thane) | Pharmaceuticals | Thane, India |
SeQuent Scientific ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
41.99 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,784
Rank
Percentile
Pharmaceuticals
Industry
of 955
Rank
Percentile
Pharmaceuticals
Subindustry
of 447
Rank
Percentile
SeQuent Scientific Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Naari Pharma India | 01-Jan-2016 | Completed |
|
SeQuent Scientific FAQs
-
When was SeQuent Scientific founded?
SeQuent Scientific was founded in 1985.
-
Who is the CEO of SeQuent Scientific?
Rajaram Narayanan is the CEO of SeQuent Scientific.
-
Where is SeQuent Scientific headquartered?
SeQuent Scientific is headquartered in Mumbai, India.
-
What is the size of SeQuent Scientific?
SeQuent Scientific has 1,358 total employees.
-
What industry is SeQuent Scientific in?
SeQuent Scientific’s primary industry is Pharmaceuticals.
-
Is SeQuent Scientific a private or public company?
SeQuent Scientific is a Public company.
-
What is SeQuent Scientific’s stock symbol?
The ticker symbol for SeQuent Scientific is 512529.
-
What is the current stock price of SeQuent Scientific?
As of 08-Oct-2024 the stock price of SeQuent Scientific is $2.45.
-
What is the current market cap of SeQuent Scientific?
The current market capitalization of SeQuent Scientific is $611M.
-
What is SeQuent Scientific’s current revenue?
The trailing twelve month revenue for SeQuent Scientific is $171M.
-
Who are SeQuent Scientific’s competitors?
Novartis India, Strides Pharma Science, Abbott India, Ajanta Pharma, and Zydus Lifesciences are some of the 54 competitors of SeQuent Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
